Differences among HIV-1 variants in their ability to elicit secretion of TNF-α

Kristen V. Khanna, Xiao Fang Yu, David H. Ford, Lee Ratner, James Hildreth, Richard B. Markham

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

HIV-1 infection of human PBMC has been shown to elicit secretion of several different cytokines. TNF-α secretion induced by this virus has been of particular interest because it has been associated with the development of HIV-1 dementia and because TNF-α increases viral replication by enhancing NF-κB interaction with the viral promoter, the HIV-1 long terminal repeat. Thus, an autocrine pathway is potentially created in which HIV-1 stimulates its own replication. Conflicting reports exist, however, on the ability of HIV-1 to induce TNF-α secretion in vitro or in vivo. Using experimental protocols that controlled for potential bacterial endotoxin-induced TNF-α secretion, the current study demonstrates significant differences in TNF-α- eliciting properties among primary and laboratory obtained HIV-1. The relative TNF-α-inducing ability of different variants is conserved when tested using PBMC from different individuals. Elicitation of TNF-α secretion was not blocked by exposure of cells to zidovudine, indicating that viral integration was not required to induce secretion. Rather, the interaction between the virus and cell surface is critical for TNF-α induction, as Abs against CD4 or CCR5 blocked the induction of TNF-α synthesis by PBMC when added before virus exposure. Furthermore, the ability to induce TNF-α secretion mapped to a region of the HIV-1 env gene that includes the third hypervariable domain. Differences in the ability of different HIV-1 variants to elicit TNF-α may account for individual differences in HIV-1 disease course.

Original languageEnglish (US)
Pages (from-to)1408-1415
Number of pages8
JournalJournal of Immunology
Volume164
Issue number3
StatePublished - Feb 1 2000
Externally publishedYes

Fingerprint

Aptitude
HIV-1
Viruses
HIV Long Terminal Repeat
AIDS Dementia Complex
Virus Integration
env Genes
Zidovudine
Individuality
Endotoxins
HIV Infections
Cytokines

ASJC Scopus subject areas

  • Immunology

Cite this

Khanna, K. V., Yu, X. F., Ford, D. H., Ratner, L., Hildreth, J., & Markham, R. B. (2000). Differences among HIV-1 variants in their ability to elicit secretion of TNF-α. Journal of Immunology, 164(3), 1408-1415.

Differences among HIV-1 variants in their ability to elicit secretion of TNF-α. / Khanna, Kristen V.; Yu, Xiao Fang; Ford, David H.; Ratner, Lee; Hildreth, James; Markham, Richard B.

In: Journal of Immunology, Vol. 164, No. 3, 01.02.2000, p. 1408-1415.

Research output: Contribution to journalArticle

Khanna, KV, Yu, XF, Ford, DH, Ratner, L, Hildreth, J & Markham, RB 2000, 'Differences among HIV-1 variants in their ability to elicit secretion of TNF-α', Journal of Immunology, vol. 164, no. 3, pp. 1408-1415.
Khanna KV, Yu XF, Ford DH, Ratner L, Hildreth J, Markham RB. Differences among HIV-1 variants in their ability to elicit secretion of TNF-α. Journal of Immunology. 2000 Feb 1;164(3):1408-1415.
Khanna, Kristen V. ; Yu, Xiao Fang ; Ford, David H. ; Ratner, Lee ; Hildreth, James ; Markham, Richard B. / Differences among HIV-1 variants in their ability to elicit secretion of TNF-α. In: Journal of Immunology. 2000 ; Vol. 164, No. 3. pp. 1408-1415.
@article{bcb2d1e950b24424b888f81f33529aad,
title = "Differences among HIV-1 variants in their ability to elicit secretion of TNF-α",
abstract = "HIV-1 infection of human PBMC has been shown to elicit secretion of several different cytokines. TNF-α secretion induced by this virus has been of particular interest because it has been associated with the development of HIV-1 dementia and because TNF-α increases viral replication by enhancing NF-κB interaction with the viral promoter, the HIV-1 long terminal repeat. Thus, an autocrine pathway is potentially created in which HIV-1 stimulates its own replication. Conflicting reports exist, however, on the ability of HIV-1 to induce TNF-α secretion in vitro or in vivo. Using experimental protocols that controlled for potential bacterial endotoxin-induced TNF-α secretion, the current study demonstrates significant differences in TNF-α- eliciting properties among primary and laboratory obtained HIV-1. The relative TNF-α-inducing ability of different variants is conserved when tested using PBMC from different individuals. Elicitation of TNF-α secretion was not blocked by exposure of cells to zidovudine, indicating that viral integration was not required to induce secretion. Rather, the interaction between the virus and cell surface is critical for TNF-α induction, as Abs against CD4 or CCR5 blocked the induction of TNF-α synthesis by PBMC when added before virus exposure. Furthermore, the ability to induce TNF-α secretion mapped to a region of the HIV-1 env gene that includes the third hypervariable domain. Differences in the ability of different HIV-1 variants to elicit TNF-α may account for individual differences in HIV-1 disease course.",
author = "Khanna, {Kristen V.} and Yu, {Xiao Fang} and Ford, {David H.} and Lee Ratner and James Hildreth and Markham, {Richard B.}",
year = "2000",
month = "2",
day = "1",
language = "English (US)",
volume = "164",
pages = "1408--1415",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Differences among HIV-1 variants in their ability to elicit secretion of TNF-α

AU - Khanna, Kristen V.

AU - Yu, Xiao Fang

AU - Ford, David H.

AU - Ratner, Lee

AU - Hildreth, James

AU - Markham, Richard B.

PY - 2000/2/1

Y1 - 2000/2/1

N2 - HIV-1 infection of human PBMC has been shown to elicit secretion of several different cytokines. TNF-α secretion induced by this virus has been of particular interest because it has been associated with the development of HIV-1 dementia and because TNF-α increases viral replication by enhancing NF-κB interaction with the viral promoter, the HIV-1 long terminal repeat. Thus, an autocrine pathway is potentially created in which HIV-1 stimulates its own replication. Conflicting reports exist, however, on the ability of HIV-1 to induce TNF-α secretion in vitro or in vivo. Using experimental protocols that controlled for potential bacterial endotoxin-induced TNF-α secretion, the current study demonstrates significant differences in TNF-α- eliciting properties among primary and laboratory obtained HIV-1. The relative TNF-α-inducing ability of different variants is conserved when tested using PBMC from different individuals. Elicitation of TNF-α secretion was not blocked by exposure of cells to zidovudine, indicating that viral integration was not required to induce secretion. Rather, the interaction between the virus and cell surface is critical for TNF-α induction, as Abs against CD4 or CCR5 blocked the induction of TNF-α synthesis by PBMC when added before virus exposure. Furthermore, the ability to induce TNF-α secretion mapped to a region of the HIV-1 env gene that includes the third hypervariable domain. Differences in the ability of different HIV-1 variants to elicit TNF-α may account for individual differences in HIV-1 disease course.

AB - HIV-1 infection of human PBMC has been shown to elicit secretion of several different cytokines. TNF-α secretion induced by this virus has been of particular interest because it has been associated with the development of HIV-1 dementia and because TNF-α increases viral replication by enhancing NF-κB interaction with the viral promoter, the HIV-1 long terminal repeat. Thus, an autocrine pathway is potentially created in which HIV-1 stimulates its own replication. Conflicting reports exist, however, on the ability of HIV-1 to induce TNF-α secretion in vitro or in vivo. Using experimental protocols that controlled for potential bacterial endotoxin-induced TNF-α secretion, the current study demonstrates significant differences in TNF-α- eliciting properties among primary and laboratory obtained HIV-1. The relative TNF-α-inducing ability of different variants is conserved when tested using PBMC from different individuals. Elicitation of TNF-α secretion was not blocked by exposure of cells to zidovudine, indicating that viral integration was not required to induce secretion. Rather, the interaction between the virus and cell surface is critical for TNF-α induction, as Abs against CD4 or CCR5 blocked the induction of TNF-α synthesis by PBMC when added before virus exposure. Furthermore, the ability to induce TNF-α secretion mapped to a region of the HIV-1 env gene that includes the third hypervariable domain. Differences in the ability of different HIV-1 variants to elicit TNF-α may account for individual differences in HIV-1 disease course.

UR - http://www.scopus.com/inward/record.url?scp=0034142377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034142377&partnerID=8YFLogxK

M3 - Article

C2 - 10640756

AN - SCOPUS:0034142377

VL - 164

SP - 1408

EP - 1415

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -